Does the treatment of cryptogenic fibrosing alveolitis influence prognosis? (Q41060148)

26 September 2017

1 reference

title

Does the treatment of cryptogenic fibrosing alveolitis influence prognosis? (English)

1 reference

26 September 2017

2

1 reference

26 September 2017

Egan JJ

1

1 reference

26 September 2017

publication date

1 March 1996

1 reference

26 September 2017

1 reference

26 September 2017

volume

90

1 reference

26 September 2017

issue

3

1 reference

26 September 2017

page(s)

127-130

1 reference

Prediction of disease progression in idiopathic pulmonary fibrosis

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990153-5

7 January 2021

The prognosis of cryptogenic fibrosing alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990153-5

7 January 2021

Cryptogenic fibrosing alveolitis: clinical features and their influence on survival

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990153-5

7 January 2021

Chronic Diffuse Interstitial Fibrosis of the Lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990153-5

7 January 2021

Natural History and Treated Course of Usual and Desquamative Interstitial Pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990153-5

7 January 2021

Idiopathic pulmonary fibrosis. A paradigm for lung injury and repair

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990153-5

7 January 2021

Outcome of subjects with idiopathic pulmonary fibrosis who fail corticosteroid therapy. Implications for further studies

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990153-5

7 January 2021

Predicted values: how should we use them?

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990153-5

7 January 2021

Clinical and functional assessment of patients with idiopathic pulmonary fibrosis: results of a 3 year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990153-5

7 January 2021

The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990153-5

7 January 2021

An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990153-5

7 January 2021

Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990153-5

7 January 2021

Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990153-5

7 January 2021

Azathioprine Combined with Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: A Prospective Double-blind, Randomized, Placebo-controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990153-5

7 January 2021

Cyclosporin as a treatment for interstitial lung disease of unknown aetiology

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990153-5

7 January 2021

Advanced cryptogenic fibrosing alveolitis: preliminary report on treatment with cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990153-5

7 January 2021

Colchicine suppresses the release of fibroblast growth factors from alveolar macrophages in vitro. The basis of a possible therapeutic approach ot the fibrotic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990153-5

7 January 2021

Colchicine in the treatment of pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990153-5

7 January 2021

Cytokines of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990153-5

7 January 2021

10.1016/S0954-6111(96)90153-5

Identifiers

DOI

1 reference

26 September 2017

1 reference